AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 760 | 0 | 0 | 0 | 0 |
Gross Profit | 760 | N/A | N/A | N/A | N/A |
Operating Expenses | 23,936 | 22,940 | 20,763 | 17,504 | 18,962 |
Operating Income | -23,177 | -22,940 | -4,276 | -17,504 | -18,962 |
Interest Expense | 38 | 41 | 32 | 29 | 30 |
Other Income | -1,952 | 2,563 | -1,311 | 398 | 270 |
Pre-tax Income | -25,166 | -20,418 | -5,619 | -17,136 | -18,722 |
Income Tax | N/A | N/A | 8 | -3 | 3 |
Net Income Continuous | -25,166 | -20,418 | -5,627 | -17,132 | -18,725 |
Net Income | $-25,166 | $-20,418 | $-5,620 | $-17,139 | $-18,725 |
EPS Basic Total Ops | -0.25 | -0.21 | -0.06 | -0.20 | -0.22 |
EPS Basic Continuous Ops | -0.25 | -0.21 | -0.06 | -0.20 | -0.22 |
EPS Diluted Total Ops | -0.25 | -0.21 | -0.06 | -0.20 | -0.22 |
EPS Diluted Continuous Ops | -0.25 | -0.21 | -0.06 | -0.20 | -0.22 |
EPS Diluted Before Non-Recurring Items | -0.25 | -0.21 | -0.06 | -0.20 | -0.22 |
EBITDA(a) | $-22,592 | $-22,304 | $-20,175 | $-16,862 | $-18,342 |